Childhood Cancer Survivor Study (CCSS, Expanded Cohort) |
US Mail/phone |
15,233 |
10,004 (66%) |
1,063 (67%) |
7615 (70%) |
842 (57%) |
198 (61%) |
– |
The Multiethnic Cohort (MEC)44
|
US Mail |
854,613 |
218,780 (30%) |
281,990 (17%) |
136,142 (34%) |
170,694 (21%) |
137,812 (44%) |
– |
Adventist Health Study 2 (AHS-2)45,46
|
Community-based |
350,000 |
96,163 (28%) |
– |
71,865 (28%) |
25,087 (28%) |
– |
– |
Genetic and Epidemiology Study of Cardiovascular Disease in Alaska Natives (GOCADAN)47,48
|
Community-based |
7,7000 |
1,214 (74%) |
– |
– |
– |
– |
1,214 (74%) |
Jackson Heart Study (JHS)49
|
Community-based |
76,420 |
5,302 (51%) |
– |
– |
5,302 (51%) |
– |
– |
National Health and Nutrition Examination Survey II (NHANES II)50
|
|
27,801 |
25,286 (91%) |
– |
21,359 (91%) |
3,389 (93%) |
– |
– |
National Health and Nutrition Examination Survey III (NHANES III)51
|
|
39.695 |
33,994# (82%) |
9,751 (87%) |
13,085 (80%) |
9,627 (86%) |
– |
– |
Strong Heart Study (SHS, American Indian)52
|
Community-based |
7,305 |
4,529# (62%) |
– |
– |
– |
– |
4,529# (62%) |
Participation rates by race and ethnicity among NIH funded, survey-based cancer survivor studiesˆ |
|
Recruitment Methodology |
Eligible (N) |
Participating (N, % of Eligible) |
TOTAL |
Hispanic |
White, Non-Hispanic |
Black, Non-Hispanic |
Asian/Pacific Islander |
Native American |
Childhood Cancer Survivor Study (CCSS, Expanded Cohort) |
US Mail/phone |
15,233 |
10,004 (66%) |
1,063 (67%) |
7615 (70%) |
842 (57%) |
198 (61%) |
– |
Project Forward Study53
|
US Mail |
470 |
235 (50%) |
121 (49%) |
80 (58%) |
– |
– |
– |
Adolescent and Young Adult Health Outcomes and Patient Experience Study (AYA-HOPE)54
|
US Mail/phone/internet |
1,208 |
524 (43%) |
97 (35%) |
331 (47%) |
42 (38%) |
– |
– |
Experience of Care and Health Outcomes of Survivors of Non-Hodgkin Lymphoma (ECHOS-NHL)55
|
US Mail |
744 |
408 (55%) |
89 (45%) |
290 (59%) |
29 (49%) |
– |
– |
Health, Eating, Activity and Lifestyle Study (HEAL)56
|
US Mail/In-person Interview |
3,070 |
856 (29%) |
429 (37%) |
671 (27%) |
1 (2%) |
14 (19%) |
|